Head Lice Infestation Drug Market to Grow at 3.6% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global head lice infestation drug market was valued at USD 372 million in 2024 and is projected to reach USD 473 million by 2031, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025–2031. Head lice infestation drugs, clinically known as pediculicides, are specialized pharmaceutical treatments designed to eradicate Pediculus humanus capitis infestations. These products work through various mechanisms including neurotoxicity, physical suffocation, or enzymatic disruption to eliminate live lice and their eggs (nits). Common formulations include shampoos, lotions, creams, and topical solutions, with shampoo-based products holding the dominant market share due to their ease of application and consumer familiarity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7268/head-lice-infestation-drug-market